Goldman Sachs’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,400
Closed -$4.28M 6340
2024
Q4
$4.28M Sell
16,400
-1,600
-9% -$403K ﹤0.01% 3598
2024
Q3
$4.19M Hold
18,000
﹤0.01% 3497
2024
Q2
$3.63M Buy
+18,000
New +$3.24M ﹤0.01% 3449
2016
Q1
Sell
-45,500
Closed -$1.72M 7261
2015
Q4
$1.72M Buy
+45,500
New +$1.53M ﹤0.01% 3776
2015
Q3
Sell
-50,000
Closed -$1.55M 7448
2015
Q2
$1.55M Sell
50,000
-100,000
-67% -$2.95M ﹤0.01% 4102
2015
Q1
$5M Buy
150,000
+100,000
+200% +$3.38M ﹤0.01% 2903
2014
Q4
$2.3M Hold
50,000
﹤0.01% 3706
2014
Q3
$1.84M Sell
50,000
-17,500
-26% -$639K ﹤0.01% 4018
2014
Q2
$2.68M Hold
67,500
﹤0.01% 3688
2014
Q1
$3.2M Buy
67,500
+58,100
+618% +$2.57M ﹤0.01% 3528
2013
Q4
$349K Sell
9,400
-40,600
-81% -$1.5M ﹤0.01% 5572
2013
Q3
$1.81M Buy
+50,000
New +$1.68M ﹤0.01% 4003

Other funds holding PODD

Goldman Sachs's PODD Position: Q1 2026 in Review

Goldman Sachs increased its Insulet (PODD) stake by 12% in Q1 2026, buying an estimated $24M and bringing the position to 863,916 shares worth $181M. The position accounts for 0.02% of the portfolio, ranked #722.

Goldman Sachs first reported a position in PODD in Q2 2013 and has held it in 52 quarters since. The position peaked at $311M in Q2 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Goldman Sachs held 863,916 shares of Insulet worth $181M as of Q1 2026.
  • Goldman Sachs bought 95,581 Insulet shares in Q1 2026, an estimated $24M.
  • Insulet made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #722 holding.
  • Goldman Sachs first reported a position in Insulet in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Insulet position peaked at $311M in Q2 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.